Development and internal validation of a steatosis index in primary biliary cholangitis: a retrospective single-center study

Hepatic steatosis may coexist with primary biliary cholangitis (PBC), but PBC-related biochemical and lipid abnormalities may complicate its identification using laboratory-based indices. We aimed to develop and internally validate a PBC-specific steatosis index (PSI) using routinely collected variables. This retrospective single-center study included adults with biopsy-confirmed PBC during 2016–2025; hepatic steatosis was defined histologically as involvement of at least 5% of hepatocytes. Missing predictors were multiply imputed within training partitions. A genetic-algorithm formula-search procedure was evaluated by repeated nested five-fold cross-validation against least absolute shrinkage and selection operator (LASSO), a prespecified clinical model, and six conventional indices. Among 681 participants, 98 (14.4%) had histological steatosis. The locked two-variable PSI formula was 5 × triglycerides − 2 × diabetes status (1 = recorded diabetes; 0 = no recorded diabetes). The PSI procedure achieved an out-of-fold AUC of 0.703 (95% CI, 0.646–0.757), Brier score of 0.116, and calibration slope of 1.276. At the exploratory OOF probability cutoff of 0.131, sensitivity was 72.4%, specificity 59.3%, positive predictive value 23.1%, and negative predictive value 92.8%. PSI outperformed HSI and TyG-BMI after multiplicity adjustment but did not demonstrate superiority over TyG or LASSO. In this biopsy-confirmed PBC cohort, the PSI procedure showed moderate internally assessed discrimination for steatosis. The transparent and readily reproducible two-variable formula may help prioritize patients for further steatosis assessment when imaging-based evaluation is not readily available, but requires independent external validation before clinical implementation.

Authors

Institutions

Publication Details

Journal
BMC Gastroenterology
Published
2026-11-19
DOI
https://doi.org/10.1186/s12876-026-05585-9
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development and internal validation of a steatosis index in primary biliary cholangitis: a retrospective single-center study

Hong-Li Liu, Yongfeng Yang, S S Li, An-Ling Zhou et al.
BMC Gastroenterology
Liver Diseases and Immunity
article

Development and internal validation of a steatosis index in primary biliary cholangitis: a retrospective single-center study

Hong-Li Liu, Yongfeng Yang, S S Li, An-Ling Zhou, Ling Li, Qun-Zeng Danzeng
article en

Abstract

Hepatic steatosis may coexist with primary biliary cholangitis (PBC), but PBC-related biochemical and lipid abnormalities may complicate its identification using laboratory-based indices. We aimed to develop and internally validate a PBC-specific steatosis index (PSI) using routinely collected variables. This retrospective single-center study included adults with biopsy-confirmed PBC during 2016–2025; hepatic steatosis was defined histologically as involvement of at least 5% of hepatocytes. Missing predictors were multiply imputed within training partitions. A genetic-algorithm formula-search procedure was evaluated by repeated nested five-fold cross-validation against least absolute shrinkage and selection operator (LASSO), a prespecified clinical model, and six conventional indices. Among 681 participants, 98 (14.4%) had histological steatosis. The locked two-variable PSI formula was 5 × triglycerides − 2 × diabetes status (1 = recorded diabetes; 0 = no recorded diabetes). The PSI procedure achieved an out-of-fold AUC of 0.703 (95% CI, 0.646–0.757), Brier score of 0.116, and calibration slope of 1.276. At the exploratory OOF probability cutoff of 0.131, sensitivity was 72.4%, specificity 59.3%, positive predictive value 23.1%, and negative predictive value 92.8%. PSI outperformed HSI and TyG-BMI after multiplicity adjustment but did not demonstrate superiority over TyG or LASSO. In this biopsy-confirmed PBC cohort, the PSI procedure showed moderate internally assessed discrimination for steatosis. The transparent and readily reproducible two-variable formula may help prioritize patients for further steatosis assessment when imaging-based evaluation is not readily available, but requires independent external validation before clinical implementation.

BMC Gastroenterology
Nanjing University of Chinese Medicine (CN), Nanjing Second Hospital (CN), Southeast University (CN), Nanjing Medical University (CN), Nanjing University (CN)
Liver Diseases and Immunity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon